A prospective, case-sectional study investigating the rate of anti-HBs seroconversion after three HBV vaccinations post-HSCT, factors associated with non-seroconversion, and the rate of seroconversion after a fourth vaccination if seroconversion did not occur after the third vaccination
Latest Information Update: 10 Jul 2020
At a glance
- Drugs DTwP HBV HIB IPV (Primary) ; Hib-DTaP-poliovirus vaccine (Primary)
- Indications Hepatitis B
- Focus Pharmacodynamics
- 10 Jul 2020 New trial record
- 01 Jul 2020 Results published in the Clinical Transplantation